Comparison between low clinical score 0–1 (N = 52) and high clinical score 2–3 (N = 49) GPC3 expression showed that there was no statistically significant difference between the two levels based on demographic characteristics, epidemiological parameters, HCC risk factors, clinicopathological characteristics, and baseline treatment modalities (Figure 1). The gene discussed is GPC3; the disease is hepatocellular carcinoma.